التفاصيل البيبلوغرافية
العنوان: |
Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM) |
المؤلفون: |
Jakubowiak, Andrzej J, Dytfeld, Dominik *, Jagannath, Sundar, Vesole, David H., Anderson, Tara B. *, Nordgren, Brian K. *, Detweiler-Short, Kristen *, Lebovic, Daniel, Stockerl-Goldstein, Keith E., Griffith, Kent A. *, Jobkar, Terri L. *, Durecki, Diane E *, Wear, Sandra M. *, Ott, Robert F *, Al-Zoubi, Ammar, Mietzel, Melissa A *, Hussein, M *, Couriel, Daniel, Leveque, Joseph A, Vij, Ravi |
المصدر: |
In Blood 18 November 2011 118(21):631-631 |
قاعدة البيانات: |
ScienceDirect |